Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Frequently asked questions
What sector does Demant A/S (WILLF) operate in?
Demant A/S belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Demant A/S (WILLF) current stock price?
As of the latest data, Demant A/S stock price is $53.06, with a previous close of $53.84. Demant A/S lost -$0.78 in the last trading session, representing a -1.45% loss.
What is Demant A/S (WILLF) current market capitalization?
Demant A/S market cap is approximately 11.19 billion.
What is Demant A/S (WILLF) Earnings Per Share (EPS)?
The trailing EPS is $1.79.
What is Demant A/S (WILLF) Price-to-Earnings (P/E) ratio?
Demant A/S current P/E ratio is 29.64.
What is Demant A/S (WILLF) EBITDA?
Demant A/S EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 3.09 billion.
Does Demant A/S (WILLF) pay dividends?
No. Demant A/S does not pay a dividend.
What is Demant A/S (WILLF) beta (volatility) score?
Demant A/S has a beta of 0.704, indicating lower volatility than the overall market.
